The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-5 of 5 articles
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program
Abdel-Wahab M,
Neumann F,
Serruys P,
Silber S,
Leon M,
Mauri L,
Yeung A,
Belardi J,
Widimský P,
Meredith I,
Saito S,
Richardt G
July 20, 2016 | 10.4244/EIJY15M07_07
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
Abizaid A,
Ormiston J,
Fajadet J,
Mauri L,
Schofer J,
Verheye S,
Dens J,
Thuesen L,
Macours N,
Qureshi A,
Spaulding C
October 25, 2013 | 10.4244/EIJV9I6A116
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
Fajadet J,
Wijns W,
Laarman GJ,
Kuck K,
Ormiston J,
Baldus S,
Hauptmann K-E,
Suttorp MJ,
Drzewiecki J,
Pieper M,
Schultheiss H-P,
Mauri L
November 15, 2010
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023